Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) During Pregnancy
ENRICH
Promoting Cardiovascular Health of Northern Appalachian Women During and After Pregnancy: PSU Maternal Pilot Study
2 other identifiers
interventional
12
1 country
2
Brief Summary
This pilot study aims to examine the feasibility and acceptability of adding a cardiovascular health module to the existing Nurse Family Partnership (NFP) home visitation program delivered by trained nurses in the Northern Appalachian region of Central Pennsylvania.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cardiovascular-diseases
Started Aug 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2023
CompletedFirst Posted
Study publicly available on registry
April 20, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedResults Posted
Study results publicly available
May 29, 2025
CompletedMay 29, 2025
May 1, 2025
11 months
March 24, 2023
April 24, 2025
May 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of Integrating a Cardiovascular Health Module to the Existing Nurse-Family Partnership (NFP) Home Visiting Program as Measured by Qualitative Feedback From Home Visitors.
Feasibility will be determined good acceptability by NFP nurses as assessed qualitatively during group discussions. Nurses will use their experience as home visitors to provide feedback to study personnel on whether they are able to successfully integrate new visit content into their usual workflow. They will further give suggestions for future improvement after completion of this pilot study.
6 months
Study Arms (1)
Maternal Cardiovascular health (CVH) Intervention
EXPERIMENTALThe pilot maternal CVH intervention will be delivered by NFP partners starting as early as NFP program enrollment in the first trimester after confirmation of a viable pregnancy and no later than the 28th week of pregnancy and will continue up to 6 months postpartum. The visit schedule will be consistent with the NFP visit structure to deliver intervention content at regularly scheduled visits that are typically 60 minutes long (weekly visits for the first month following enrollment followed by twice monthly visits until delivery). The pilot study will include an enhanced behavioral component target decreased sedentary time and increase physical activity and utilizing a technology/monitoring component. All women be monitored using a wrist-worn actigraphy device to record daily activity, intermittent home blood pressure self-monitoring, intermittent home weight self-monitoring, and carbon monoxide monitoring administered by the NFP nurse.
Interventions
All participants will be enrolled into the intervention arm of this pilot study.
Eligibility Criteria
You may qualify if:
- Nulliparous pregnant woman
- Age ≥ 18 years old
- Enrolled in and receiving the Nurse-Family Partnership program through the Geisinger Clinic or UPMC Home Health Care of Central PA
- English speaking
- Women with a singleton viable pregnancy confirmed by NFP home visitors
- Access to reliable internet service required for data collection
- A minimum of 5 women with use of nicotine containing products (cigarette, cigar, hookah, chewing tobacco, e-cigarette, patch) within the past 3 months
You may not qualify if:
- Unable or unwilling to comply with the study visits and procedures
- Participation in a concurrent interventional study
- Diagnosis of cancer
- A personal history of complex congenital heart disease
- A fetus in the current pregnancy with known chromosomal abnormalities or birth defects inconsistent with survival to 2 years will be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
UPMC Home Health
Altoona, Pennsylvania, 16601, United States
Geisinger
Danville, Pennsylvania, 17822, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Ian Paul
- Organization
- Penn State College of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Ian M Paul, MD, MSc
Penn State University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics and Public Health Sciences; Chief, Division of Academic General Pediatrics; Vice Chair of Faculty Affairs, Department of Pediatrics Affiliation: Penn State University
Study Record Dates
First Submitted
March 24, 2023
First Posted
April 20, 2023
Study Start
August 1, 2023
Primary Completion
June 30, 2024
Study Completion
December 31, 2024
Last Updated
May 29, 2025
Results First Posted
May 29, 2025
Record last verified: 2025-05